Searched over 200M research papers for "stroke pathophysiology"
10 papers analyzed
These studies suggest that stroke pathophysiology involves a complex interplay of hemodynamic, molecular, cellular, and systemic factors, with therapeutic approaches focusing on restoring blood flow, targeting cell signaling mechanisms, and understanding the roles of immune cells and long non-coding RNAs.
20 papers analyzed
Stroke is a leading cause of death and disability worldwide, with ischemic stroke being the most prevalent type. The pathophysiology of stroke involves a complex interplay of hemodynamic, molecular, and systemic factors that contribute to brain injury and subsequent neurological deficits . This article synthesizes current research to provide a comprehensive overview of the mechanisms underlying stroke pathophysiology.
Stroke occurs due to a critical reduction in cerebral blood flow, often resulting from the obstruction of a large brain artery. This reduction leads to oxygen and glucose deprivation, triggering a cascade of events that culminate in neuronal death. The regulation of blood flow, including the role of collateral circulation and microcirculation, is crucial in understanding the extent of ischemic damage.
The concept of the ischemic penumbra is central to stroke pathophysiology. It refers to the area surrounding the infarct core that experiences milder ischemic insults. In this region, cells are at risk but not yet irreversibly damaged, making it a critical target for therapeutic interventions. Understanding the physiological, biochemical, and structural viability thresholds of the penumbra is essential for developing imaging techniques and treatment strategies.
Following ischemia, prolonged activation of excitatory neurotransmitter receptors leads to intracellular calcium accumulation and oxidative stress. These processes contribute to neuronal injury and death . The role of excitotoxicity and oxidative stress in stroke pathophysiology highlights potential targets for neuroprotective therapies.
Inflammation plays a significant role in the progression of ischemic injury. The infiltration of peripheral immune cells and the activation of resident brain cells contribute to the inflammatory response, exacerbating tissue damage . Additionally, apoptosis, or programmed cell death, is a key mechanism in the delayed neuronal death observed in the ischemic penumbra .
Stroke induces a systemic immune response, characterized by peripheral immunodepression and hyperactivation of autonomic and neuroendocrine pathways. This response can lead to complications such as infections, which significantly impact patient outcomes . Understanding the bidirectional interactions between the brain and peripheral organs is crucial for developing comprehensive treatment approaches.
Acute ischemic stroke can result in dysfunction of various organ systems, including the respiratory, urinary, cardiovascular, gastrointestinal, musculoskeletal, and endocrine systems. These systemic effects contribute to the morbidity and mortality associated with stroke. Recognizing stroke as a systemic disease underscores the need for holistic management strategies.
Animal models have been instrumental in elucidating the pathophysiological mechanisms of stroke. These models have helped identify the spatiotemporal patterns of brain injury, including early excitotoxicity and delayed inflammatory responses. Experimental studies have also highlighted the potential of ischemic preconditioning as a protective strategy against stroke.
Recent research has identified long non-coding RNAs (lncRNAs) as important regulators of stroke pathophysiology. Altered expression of lncRNAs in stroke patients and animal models suggests their potential as biomarkers for diagnosis, treatment, and prognosis. Targeting specific lncRNAs could offer new therapeutic avenues for ischemic stroke.
The pathophysiology of stroke is a multifaceted process involving hemodynamic disturbances, molecular injury pathways, and systemic responses. Advances in understanding these mechanisms have paved the way for novel therapeutic targets and comprehensive treatment strategies. Continued research is essential to further unravel the complexities of stroke and improve patient outcomes.
Most relevant research papers on this topic